In patients with sarcopenia, CHI3L1 is upregulated and secreted by skeletal muscle via the TNF-α/TNFR1 signaling pathway, protecting myocytes from damage, while concurrently promoting HCC progression by inducing the accumulation of LPO products. Here, TNFRSF1A is linked to sarcopenia.